SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001461993-19-000011
Filing Date
2019-05-09
Accepted
2019-05-09 16:16:38
Documents
2
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q1 2019 EARNINGS q12019earnings8-k.htm 8-K 28042
2 EXHIBIT 99.1 EARNINGS RELEASE Q1 2019 ex991q12019earningsrelease.htm EX-99.1 279978
  Complete submission text file 0001461993-19-000011.txt   309301
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 19810759
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences